EndoPredict is available in several countries worldwide.

Outside of the USA, physicians and pathologists have 2 options to make EndoPredict available for their patients. The test can be performed:

  • in a local molecular pathology laboratory. Please check out the list of the available centers
  • or at the Myriad central laboratory in Salt Lake City, USA

EndoPredict can be performed on estrogen-receptor-positive (ER+), HER2-negative, primary, invasive female breast tumors from patients who have not received systemic endocrine therapy and/or chemotherapy.

Once the sample has been sent to the laboratory, results are usually available within 1 week.

For more information on how to order EndoPredict, please do not hesitate to contact your Myriad local representative or to send us an E-mail at info@myriadgenetics.eu and we will be pleased to guide you through the test process.

If you would like information concerning the possibilities to install an EndoPredict platform in your pathology laboratory, we invite you to contact us and to review the information contained in the different sections of the providers tab.